Mar 04, 2016, 09:00 ET from Zimmer Biomet Holdings, Inc.
, /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, has announced that it has secured an exclusive global distribution agreement with CelgenTek Innovations Corporation, which includes its N-Force Fixation System and iN3 Cement. This innovative bone void-filling solution allows healthcare professionals to directly administer Zimmer Biomet's N-Force Blue–Bone Substitute Material (BSM) (available in) and CelgenTek's iN3 Cement (available in the European Union) directly through a fenestrated screw in a single integrated construct. The financial terms of the transaction were not disclosed.
About Zimmer Biomet
Founded in 1927 and headquartered in , Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.